Lixa
2 known investors
Lixa develops NeoX, a platform technology that targets antimicrobial resistance (AMR) by switching off bacteria's resistance mechanisms, restoring the effectiveness of existing antibiotics, biocides, and other antimicrobial treatments against multi-drug resistant bacteria. The technology is designed for use across human health, industrial systems, shipping, and agribusiness.
BiotechDeep TechHealthtech
Investors · 2
Frequently asked questions
- What does Lixa do?
- Lixa develops NeoX, a platform technology that targets antimicrobial resistance (AMR) by switching off bacteria's resistance mechanisms, restoring the effectiveness of existing antibiotics, biocides, and other antimicrobial treatments against multi-drug resistant bacteria. The technology is designed for use across human health, industrial systems, shipping, and agribusiness.
- Who are Lixa's investors?
- Lixa's investors include CERI, Melt Ventures.